Establishment Labs Executive and Leadership Team

September, 2026

Leadership Overview

Establishment Labs has 5 executives leading key functions including corporate strategy, founder vision, financial operations, technological innovation, and legal compliance.

Focused on advancing women's health through medical technology, Establishment Labs delivers innovative breast health and reconstruction solutions to global markets while maintaining a commitment to scientific excellence and engineering precision.

Leadership Roles at Establishment Labs

  • Chief Executive Officer - Peter Caldini
  • Founder & Chief Executive Officer - Juan Chacon Quiros
  • Chief Financial Officer - Sandra Harris
  • Chief Technology Officer - Roberto de Mezerville
  • Chief Compliance Officer & General Counsel - Ross Mansbach
  • Peter Caldini - Chief Executive Officer

    Peter Caldini, the Chief Executive Officer at Establishment Labs, directs the overarching corporate strategy and global commercial expansion. Caldini manages the execution of long-term growth initiatives, ensuring the company maintains a competitive edge in the Femtech sector. By aligning internal resources with market demands, the Chief Executive Officer optimizes the delivery of breast health solutions across international territories. Peter Caldini monitors performance metrics to drive operational efficiency and shareholder value. This leadership role involves coordinating with the Board to refine the product roadmap and expand the reach of the Motiva Flora and Mia Femtech platforms. Through rigorous oversight of commercial activities, the Chief Executive Officer secures the company's position as a leader in medical technology. Caldini fosters a culture of innovation, ensuring that every strategic decision supports the mission of improving women's health outcomes through advanced engineering and scientific research.
    Peter Caldini

    Juan Chacon Quiros - Founder & Chief Executive Officer

    Juan Chacon Quiros, the Founder & Chief Executive Officer at Establishment Labs, architects the foundational vision and long-term scientific trajectory of the organization. Quiros drives the development of breakthrough innovations, specifically focusing on the integration of advanced technology into breast aesthetics and reconstruction. As the Founder & Chief Executive Officer, Quiros oversees the research and development pipeline, ensuring that all scientific studies and patent applications align with the company's core mission. Juan Chacon Quiros maintains deep engagement with the global medical community to validate the efficacy of the Motiva Flora and Mia Femtech platforms. By championing a culture of scientific rigor, the Founder & Chief Executive Officer ensures that every product meets the highest standards of safety and performance. This leadership role involves shaping the company's identity as a pioneer in Femtech, ultimately influencing the future of women's health through continuous technological advancement and clinical excellence.
    Juan Chacon Quiros

    Sandra Harris - Chief Financial Officer

    Sandra Harris, the Chief Financial Officer at Establishment Labs, manages the financial health and capital allocation strategies necessary to support global operations. Harris oversees fiscal planning, investor relations, and the rigorous financial reporting required for a NASDAQ-listed entity. As the Chief Financial Officer, Harris ensures that the company maintains the liquidity needed to fund ongoing research and development for breast health innovations. Sandra Harris directs the financial modeling for new market entries, assessing the economic viability of expanding the Mia Femtech experience into diverse geographic regions. By maintaining strict control over operational expenditures, the Chief Financial Officer supports the company's ability to scale production and meet international demand. This leadership role involves collaborating with the executive team to align financial goals with the broader corporate mission. Harris secures the fiscal stability required to sustain long-term growth and deliver value to stakeholders through disciplined financial management.
    Sandra Harris

    Roberto de Mezerville - Chief Technology Officer

    Roberto de Mezerville, the Chief Technology Officer at Establishment Labs, directs the engineering and technical development of the company's medical device portfolio. Mezerville oversees the design and manufacturing processes for the Motiva Flora tissue expander, ensuring that all products meet stringent regulatory requirements. As the Chief Technology Officer, Mezerville manages the intellectual property strategy, protecting the company's extensive patent portfolio through continuous innovation. Roberto de Mezerville leads the technical teams responsible for the development of the Mia Femtech platform, focusing on minimally invasive solutions that improve patient outcomes. By integrating advanced materials science with clinical engineering, the Chief Technology Officer ensures that the company remains at the forefront of breast reconstruction technology. This leadership role involves coordinating with clinical researchers to translate scientific findings into scalable medical products. Mezerville drives the technical roadmap, ensuring that engineering capabilities consistently support the company's mission to advance women's health.
    Roberto de Mezerville

    Ross Mansbach - Chief Compliance Officer & General Counsel

    Ross Mansbach, the Chief Compliance Officer & General Counsel at Establishment Labs, directs the legal framework and regulatory adherence for all global operations. Mansbach manages the complex landscape of international medical device regulations, ensuring that the company maintains compliance in every market where products are distributed. As the Chief Compliance Officer & General Counsel, Mansbach oversees corporate governance and risk management, protecting the organization from legal exposure. Ross Mansbach provides strategic guidance on intellectual property protection, working closely with the technology team to secure patents for new innovations. By establishing robust internal policies, the Chief Compliance Officer & General Counsel ensures that all business activities align with ethical standards and regulatory requirements. This leadership role involves navigating the legal complexities of global expansion, facilitating the safe and efficient delivery of breast health solutions. Mansbach secures the company's operational integrity through proactive legal oversight and comprehensive regulatory strategy.
    Ross Mansbach

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding Establishment Labs Top Executives and Leadership Team

    Who leads Establishment Labs?
    Establishment Labs is led by Peter Caldini (Chief Executive Officer), along with executives such as Juan Chacon Quiros (Founder & Chief Executive Officer) and Sandra Harris (Chief Financial Officer).
    Who is part of Establishment Labs’s executive team?
    The executive team of Establishment Labs includes leaders such as Peter Caldini (Chief Executive Officer), Juan Chacon Quiros (Founder & Chief Executive Officer), Sandra Harris (Chief Financial Officer) and other senior executives.
    How many executives does Establishment Labs have?
    Establishment Labs has 5 executives leading key business areas.
    What roles are included in Establishment Labs’s leadership team?
    The leadership team of Establishment Labs includes roles such as Chief Executive Officer, Founder & Chief Executive Officer, Chief Financial Officer, Chief Technology Officer, Chief Compliance Officer & General Counsel.